×
ADVERTISEMENT

SEPTEMBER 19, 2022

Medtronic Receives FDA Clearance for Patient Monitor Designed to Detect Respiratory Compromise


Medtronic received FDA clearance for its new patient monitor, RespArray, which is intended for procedural sedation and medical-surgical units.

RespArray is engineered with Nellcor pulse oximetry and Microstream capnography, as well as ECG, noninvasive blood pressure and temperature monitoring. Designed with smart algorithms, the patient monitor helps detect respiratory compromise early and reduce alarm fatigue. It also features simple connectivity and seamlessly integrates into the